Similar articles

• Oral erythromycin and the risk of sudden death.

  Kaplan EL. Kaplan EL. N Engl J Med. 2005 Jan 20;352(3):301-4; author reply 301-4. doi: 10.1056/NEJM200501203520317. N Engl J Med. 2005. PMID: 15659735 No abstract available.
• Combining erythromycin with other drugs may lead to sudden death.

  [No authors listed] [No authors listed] Mayo Clin Womens Healthsource. 2005 Mar;9(3):3. Mayo Clin Womens Healthsource. 2005. PMID: 15689849 No abstract available.
• Warning against using erythromycin (even orally) while using protease inhibitors or certain other drugs.

  [No authors listed] [No authors listed] AIDS Treat News. 2004 Sep 24;(405):6. AIDS Treat News. 2004. PMID: 15595151
• On the assessment of effects of food on the pharmacokinetics of drugs in early development.

  Li Z, Vachharajani NN, Krishna R. Li Z, et al. Biopharm Drug Dispos. 2002 May;23(4):165-71. doi: 10.1002/bdd.309. Biopharm Drug Dispos. 2002. PMID: 12015791 Review.
• Inhibition of cytochrome P450 3A: relevant drug interactions in gastroenterology.

  Sagir A, Schmitt M, Dilger K, Häussinger D. Sagir A, et al. Digestion. 2003;68(1):41-8. doi: 10.1159/000073224. Epub 2003 Aug 29. Digestion. 2003. PMID: 12949438 Review.